ID

31708

Beschreibung

Long Acting Phosphodiesterase 5 Inhibitors as Add-on Therapy for Patients With Pulmonary Hypertension Treated With Prostanoids.; ODM derived from: https://clinicaltrials.gov/show/NCT00705588

Link

https://clinicaltrials.gov/show/NCT00705588

Stichworte

Versionen (1)
  1. 22.09.18 22.09.18 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

22. September 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Pulmonary Arterial Hypertension NCT00705588

Englisch

Eligibility Pulmonary Arterial Hypertension NCT00705588

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
all patients must satisfy current diagnostic criteria for pulmonary artery hypertension based on their historical right heart catheter data (within 3 years of study enrollment): mean pap >25mmhg at rest or >30mmhg with exercise, by a pcwp< 15mmhg and by pvr >3 wood units.
Beschreibung

Pulmonary arterial hypertension Right heart Catheter Data | Mean pulmonary arterial pressure At rest | Mean pulmonary arterial pressure Exercise induced | Pulmonary Capillary Wedge Pressure | Pulmonary Vascular Resistance Wood units Quantity

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2973725
UMLS CUI [1,2]
C0225808
UMLS CUI [1,3]
C0085590
UMLS CUI [1,4]
C1511726
UMLS CUI [2,1]
C3854605
UMLS CUI [2,2]
C0443144
UMLS CUI [3,1]
C3854605
UMLS CUI [3,2]
C0239313
UMLS CUI [4]
C0086879
UMLS CUI [5,1]
C0456261
UMLS CUI [5,2]
C0439525
UMLS CUI [5,3]
C1265611
currently stable for at least 3 months on prostanoid monotherapy (epoprostenol iv or iloprost inhaled).
Beschreibung

Prostanoid Stable | Epoprostenol Intravenous | Iloprost Inhalation

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0033554
UMLS CUI [1,2]
C0205360
UMLS CUI [2,1]
C0033567
UMLS CUI [2,2]
C1522726
UMLS CUI [3,1]
C0079594
UMLS CUI [3,2]
C0205535
willing and able to participate in all study follow-up procedures.
Beschreibung

Participation Follow-up

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0679823
UMLS CUI [1,2]
C3274571
new york heart association (nyha) class ii-iv.
Beschreibung

New York Heart Association Classification

Datentyp

boolean

Alias
UMLS CUI [1]
C1275491
six minute walking distance between 100-450 meters at the baseline assessment.
Beschreibung

6-Minute Walk Test Meter Quantity

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0430515
UMLS CUI [1,2]
C0475209
UMLS CUI [1,3]
C1265611
women of child-bearing age must demonstrate adequate contraception or undergo a pregnancy test.
Beschreibung

Childbearing Potential Contraceptive methods | Childbearing Potential Pregnancy Test

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0032976
patients with congenital heart disease are eligible for inclusion.
Beschreibung

Congenital heart disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0152021
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
functional class nyha class i.
Beschreibung

New York Heart Association Classification

Datentyp

boolean

Alias
UMLS CUI [1]
C1275491
pah due to chronic pulmonary thromboembolic disease, left heart disease, chronic lung diseases (vc or fev1 < 60% of predicted) or chronic hypoxia.
Beschreibung

Pulmonary arterial hypertension Due to Chronic pulmonary thromboembolism | Pulmonary hypertension due to left heart disease | Pulmonary arterial hypertension Due to Chronic lung disease | Percentage of predicted vital capacity | Percent predicted FEV1 | Pulmonary arterial hypertension Due to HYPOXIA CHRONIC

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2973725
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C3873396
UMLS CUI [2]
C3532326
UMLS CUI [3,1]
C2973725
UMLS CUI [3,2]
C0678226
UMLS CUI [3,3]
C0746102
UMLS CUI [4]
C2919340
UMLS CUI [5]
C0730561
UMLS CUI [6,1]
C2973725
UMLS CUI [6,2]
C0678226
UMLS CUI [6,3]
C0745190
acute intercurrent illness requiring hospital admission in the month proceeding screening.
Beschreibung

Comorbidity Hospitalization Required

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C1708385
any non-pah medical condition likely to interfere with participation in evaluation of study endpoints, e.g. musculoskeletal disorders.
Beschreibung

Medical condition Interferes with Evaluation Endpoints | Musculoskeletal Diseases | Exception Pulmonary arterial hypertension

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C1261322
UMLS CUI [1,4]
C2349179
UMLS CUI [2]
C0026857
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C2973725
any uncontrolled or terminal non-pah medical condition likely to interfere with completion of the study, according to the judgment of the study physician.
Beschreibung

Medical condition Uncontrolled Interferes with Completion of clinical trial | Condition terminal Interferes with Completion of clinical trial

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C0205318
UMLS CUI [1,3]
C0521102
UMLS CUI [1,4]
C2732579
UMLS CUI [2,1]
C2051439
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C2732579
concomitant therapy with drugs known to interact adversely with the study drug.
Beschreibung

Adverse drug interaction Investigational New Drugs

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0678798
UMLS CUI [1,2]
C0013230
chronic renal failure - creatinine clearance <50ml/min as calculated with the cockcroft equation.
Beschreibung

Kidney Failure, Chronic | Estimation of creatinine clearance by Cockcroft-Gault formula

Datentyp

boolean

Alias
UMLS CUI [1]
C0022661
UMLS CUI [2]
C2711451
current participation in another clinical trial.
Beschreibung

Study Subject Participation Status

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
pregnancy or planned pregnancy during the study period.
Beschreibung

Pregnancy | Pregnancy, Planned

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0032992
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Pulmonary Arterial Hypertension NCT00705588

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Pulmonary arterial hypertension Right heart Catheter Data | Mean pulmonary arterial pressure At rest | Mean pulmonary arterial pressure Exercise induced | Pulmonary Capillary Wedge Pressure | Pulmonary Vascular Resistance Wood units Quantity
Item
all patients must satisfy current diagnostic criteria for pulmonary artery hypertension based on their historical right heart catheter data (within 3 years of study enrollment): mean pap >25mmhg at rest or >30mmhg with exercise, by a pcwp< 15mmhg and by pvr >3 wood units.
boolean
C2973725 (UMLS CUI [1,1])
C0225808 (UMLS CUI [1,2])
C0085590 (UMLS CUI [1,3])
C1511726 (UMLS CUI [1,4])
C3854605 (UMLS CUI [2,1])
C0443144 (UMLS CUI [2,2])
C3854605 (UMLS CUI [3,1])
C0239313 (UMLS CUI [3,2])
C0086879 (UMLS CUI [4])
C0456261 (UMLS CUI [5,1])
C0439525 (UMLS CUI [5,2])
C1265611 (UMLS CUI [5,3])
Prostanoid Stable | Epoprostenol Intravenous | Iloprost Inhalation
Item
currently stable for at least 3 months on prostanoid monotherapy (epoprostenol iv or iloprost inhaled).
boolean
C0033554 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0033567 (UMLS CUI [2,1])
C1522726 (UMLS CUI [2,2])
C0079594 (UMLS CUI [3,1])
C0205535 (UMLS CUI [3,2])
Participation Follow-up
Item
willing and able to participate in all study follow-up procedures.
boolean
C0679823 (UMLS CUI [1,1])
C3274571 (UMLS CUI [1,2])
New York Heart Association Classification
Item
new york heart association (nyha) class ii-iv.
boolean
C1275491 (UMLS CUI [1])
6-Minute Walk Test Meter Quantity
Item
six minute walking distance between 100-450 meters at the baseline assessment.
boolean
C0430515 (UMLS CUI [1,1])
C0475209 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Childbearing Potential Contraceptive methods | Childbearing Potential Pregnancy Test
Item
women of child-bearing age must demonstrate adequate contraception or undergo a pregnancy test.
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C3831118 (UMLS CUI [2,1])
C0032976 (UMLS CUI [2,2])
Congenital heart disease
Item
patients with congenital heart disease are eligible for inclusion.
boolean
C0152021 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
New York Heart Association Classification
Item
functional class nyha class i.
boolean
C1275491 (UMLS CUI [1])
Pulmonary arterial hypertension Due to Chronic pulmonary thromboembolism | Pulmonary hypertension due to left heart disease | Pulmonary arterial hypertension Due to Chronic lung disease | Percentage of predicted vital capacity | Percent predicted FEV1 | Pulmonary arterial hypertension Due to HYPOXIA CHRONIC
Item
pah due to chronic pulmonary thromboembolic disease, left heart disease, chronic lung diseases (vc or fev1 < 60% of predicted) or chronic hypoxia.
boolean
C2973725 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C3873396 (UMLS CUI [1,3])
C3532326 (UMLS CUI [2])
C2973725 (UMLS CUI [3,1])
C0678226 (UMLS CUI [3,2])
C0746102 (UMLS CUI [3,3])
C2919340 (UMLS CUI [4])
C0730561 (UMLS CUI [5])
C2973725 (UMLS CUI [6,1])
C0678226 (UMLS CUI [6,2])
C0745190 (UMLS CUI [6,3])
Comorbidity Hospitalization Required
Item
acute intercurrent illness requiring hospital admission in the month proceeding screening.
boolean
C0009488 (UMLS CUI [1,1])
C1708385 (UMLS CUI [1,2])
Medical condition Interferes with Evaluation Endpoints | Musculoskeletal Diseases | Exception Pulmonary arterial hypertension
Item
any non-pah medical condition likely to interfere with participation in evaluation of study endpoints, e.g. musculoskeletal disorders.
boolean
C3843040 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C1261322 (UMLS CUI [1,3])
C2349179 (UMLS CUI [1,4])
C0026857 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C2973725 (UMLS CUI [3,2])
Medical condition Uncontrolled Interferes with Completion of clinical trial | Condition terminal Interferes with Completion of clinical trial
Item
any uncontrolled or terminal non-pah medical condition likely to interfere with completion of the study, according to the judgment of the study physician.
boolean
C3843040 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0521102 (UMLS CUI [1,3])
C2732579 (UMLS CUI [1,4])
C2051439 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C2732579 (UMLS CUI [2,3])
Adverse drug interaction Investigational New Drugs
Item
concomitant therapy with drugs known to interact adversely with the study drug.
boolean
C0678798 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
Kidney Failure, Chronic | Estimation of creatinine clearance by Cockcroft-Gault formula
Item
chronic renal failure - creatinine clearance <50ml/min as calculated with the cockcroft equation.
boolean
C0022661 (UMLS CUI [1])
C2711451 (UMLS CUI [2])
Study Subject Participation Status
Item
current participation in another clinical trial.
boolean
C2348568 (UMLS CUI [1])
Pregnancy | Pregnancy, Planned
Item
pregnancy or planned pregnancy during the study period.
boolean
C0032961 (UMLS CUI [1])
C0032992 (UMLS CUI [2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video